Double-blind Randomized Phase 2 Results Comparing Concurrent High-dose Cisplatin Chemorradiation (CRT) plus Debio 1143 or Placebo In High-risk Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): A GORTEC Study

J. Bourhis, X. Sun, Y. Pointreau, C. Sire, C. Le Tourneau, A. Coutte, M. Kaminsky-Forrett, M. Alfonsi, P. Boisselier, L. Martin, J. Delord, F. Clatot, J. Miroir, F. Rolland, P. Crompton, S. Brienza, S.A. Szyldergemajn, C. Even, Y. Tao

Annals of Oncology (2019) 30 (suppl_5): v851-v934. 10.1093/annonc/mdz394

Double-blind Randomized Phase 2 Results Comparing Concurrent High-dose Cisplatin Chemorradiation (CRT) plus Debio 1143 or Placebo In High-risk Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): A GORTEC Study by Jean Bourhis

ELAN FIT ELAN UNFIT

Barcelona 2019 ESMO Congress - Oral Presentation

Personalized treatment according to geriatric assessment in 1st line recurrent and/or metastatic (r/m) Head and Neck Squamous Cell Cancer (HNSCC) patients aged 70 or over.
Publication PDF

J. Guigay, A. Auperin, C. Mertens, C. Even, L. Geoffrois, D. Cupissol, F. Rolland, C. Sire, J. Fayette, F. Peyrade, E. Blot, P. Debourdeau, L. Bozec Le Moal, O. Capitain, Y. Pointreau, C. Brard, C. Michel, D. Schwob, C. Ortholan, H. Le Caer